
Veeva Systems (VEEV) Advances While Market Declines: Some Information for Investors
Veeva Systems (VEEV) concluded the recent trading session at $222.21, signifying a +1.49% move from its prior day's close.
Loading news...

Veeva Systems (VEEV) concluded the recent trading session at $222.21, signifying a +1.49% move from its prior day's close.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Veeva Systems Inc. (VEEV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

After seeing big-time declines in their share prices recently, three large software stocks just announced significant buyback programs. The combination of falling shares and new buybacks is often a signal that a firm sees its stock as undervalued.

Nisa Investment Advisors LLC lessened its stake in shares of Veeva Systems Inc. (NYSE: VEEV) by 31.3% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,498 shares of the technology company's stock after selling 6,595 shares during the period.

Commonwealth Equity Services LLC boosted its stake in Veeva Systems Inc. (NYSE: VEEV) by 95.2% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 46,192 shares of the technology company's stock after acquiring an additional 22,527 shares during the period. Commonwealth Equity

/PRNewswire/ -- Veeva Systems (NYSE: VEEV) und BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) gaben eine langfristige Unternehmensvereinbarung bekannt, die auf

/PRNewswire/ -- Veeva Systems (NYSE: VEEV) kündigte heute eine neue Lösung zur Umweltüberwachung (EM) an, um die Qualitätskontrolle (QC) in der Produktion zu

PLEASANTON, Calif., Jan. 8, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference: J.P.

/PRNewswire/ -- Veeva Systems (NYSE: VEEV) y BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) anunciaron un acuerdo empresarial a largo plazo que se basa en su

Partnership to help BioMarin increase speed and efficiency in developing and commercializing innovative therapies PLEASANTON, Calif., and SAN RAFAEL, Calif.

/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced today announced a new environmental monitoring (EM) solution to advance quality control (QC) for

Veeva's expanded manufacturing QC solutions to automate environmental sample collection and analysis PLEASANTON, Calif., Jan. 8, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a new environmental monitoring (EM) solution to advance quality control (QC) for manufacturing operations.

Shares of Novo Nordisk rose about 1.5% on early Wednesday after its International Operations unit committed to using Veeva Systems' Vault CRM platform.The agree

Chooses industry leading Vault CRM to empower commercial teams with next-generation CRM capabilities and agentic AI PLEASANTON, Calif., Jan. 7, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Novo Nordisk's International Operations business unit has committed to use Veeva Vault CRM.

/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Novo Nordisk's International Operations business unit has committed to use Veeva Vault CRM. "We

PLEASANTON, Calif., Jan. 5, 2026 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced that its Board of Directors approved a share repurchase program with authorization to purchase up to $2 billion of shares of its Class A common stock.

Software stocks have been hit by fears of competition from artificial intelligence but these five companies can thrive in the AI era, according to Oppenheimer analysts.